Ping-Tsung Chen
Overview
Explore the profile of Ping-Tsung Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
553
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen M, Chen P, Hsieh C, Wang C
Cells
. 2023 Jan;
12(2).
PMID: 36672266
Radiotherapy with proton therapy (PT) has dosimetric advantages over photon therapy, which helps to enlarge the therapeutic window of radiotherapy for hepatocellular carcinoma (HCC). We evaluated the response of HCC...
2.
Chuang P, Chen P, Wang C, Su W, Chen Y, Huang E
Int J Mol Sci
. 2022 May;
23(10).
PMID: 35628336
Radioresistance remains a major clinical challenge in cervical cancer therapy and results in tumor relapse and metastasis. Nevertheless, the detailed mechanisms are still largely enigmatic. This study was conducted to...
3.
Chen P, Hsieh C, Chen M
Mol Carcinog
. 2022 May;
61(8):787-796.
PMID: 35611989
Locoregional control is a significant prognostic factor for hepatocellular carcinoma (HCC). Historically, the use of radiotherapy (RT) for HCC was limited owing to the low radiotolerance of the liver and...
4.
Wu Y, You J, Huang C, Hsu C, Chen Y, Tsou H, et al.
Transl Cancer Res
. 2022 Feb;
9(10):6116-6127.
PMID: 35117223
Background: Aberrant MYC and BCL2 expression, cell of origin (COO), and National Comprehensive Cancer Network international prognostic index (NCCN-IPI) are commonly used for risk assessment and treatment decision in patients...
5.
Huang E, Lu A, Tsai Y, Wang T, Chuang H, Chen W, et al.
Medicine (Baltimore)
. 2021 Oct;
100(40):e27341.
PMID: 34622832
Background: Ethmoid or sphenoid intestinal-type adenocarcinomas (ITACs) form a distinct subtype of sinonasal adenocarcinomas that occur less than 1 case/100,000/yr. They have obvious exposure relationship to hardwood or leather dusts,...
6.
Chen M, Hsieh C, Chen P, Lu M
Nutrients
. 2021 Sep;
13(9).
PMID: 34578883
Undernourishment is reported to impair treatment response, further leading to poor prognosis for cancer patients. We aimed to investigate the role of nutritional status on the prognosis of squamous cell...
7.
Lung J, Hung M, Lin Y, Jiang Y, Fang Y, Lu M, et al.
Sci Rep
. 2021 Jun;
11(1):12952.
PMID: 34131256
No abstract available.
8.
Lung J, Hung M, Lin Y, Jiang Y, Fang Y, Lu M, et al.
Sci Rep
. 2020 Oct;
10(1):16943.
PMID: 33037234
Mutations that lead to constitutive activation of key regulators in cellular processes are one of the most important drivers behind vigorous growth of cancer cells, and are thus prime targets...
9.
Huang C, Wu Y, Hsu C, Chen Y, Tsou H, Li C, et al.
J Formos Med Assoc
. 2020 Sep;
120(2):863-873.
PMID: 32873465
Background/purpose: Ropeginterferon alpha-2b (Ropeg) is a novel pegylated interferon-alpha recently approved for the treatment of polycythemia vera (PV) in Europe. However, other than data from clinical trials, little is known...
10.
Hung C, Hsueh S, Lu C, Chang P, Chen P, Yeh K, et al.
Support Care Cancer
. 2020 Jul;
29(3):1509-1518.
PMID: 32710174
Background: No gold standard of nutritional assessment is established among patients with head and neck cancer (HNC) receiving concurrent chemoradiotherapy (CCRT). This study aimed to evaluate the clinical significance of...